Literature DB >> 22239992

Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia.

Claire Pouplard1, Pascale Cornillet-Lefebvre, Redha Attaoua, Dorothée Leroux, Carinne Lecocq-Lafon, Jérôme Rollin, Florin Grigorescu, Philippe Nguyen, Yves Gruel.   

Abstract

INTRODUCTION: Heparin-induced thrombocytopenia (HIT) results from an atypical immune response with synthesis of IgG antibodies (Abs) to platelet factor 4/heparin complexes (PF4/H), and probably involves both B and T cells. We investigated whether 3 single nucleotide polymorphisms (SNPs), rs1800896 (-1082G/A), rs1800871 (-819C/T) and rs1800872 (-592C/A) and the polymorphic CA repeat microsatellites IL10R [5325CA(11_15)] and IL10G [8134CA(14_29)] are associated with the synthesis of Abs to PF4/heparin and HIT.
MATERIALS AND METHODS: Eighty-two patients with definite HIT and two control groups were studied. The first control group (Ab(neg)) consisted of 85 patients without Abs to PF4/heparin after cardiopulmonary bypass (CPB). The second control group (Ab(pos)) consisted of 84 patients who had developed significant levels of PF4-specific antibodies after CPB, but without HIT.
RESULTS: Allele frequencies of the 3 SNPs were similar in HIT patients and controls. Fourteen alleles in IL10G (G16 to G29) and 3 alleles in IL10R (R13 to R15) were defined. The short G20 allele of IL10G was more frequent in Ab(neg) patients (8.2%) than in Ab(pos) (2.9%) and HIT patients (3%). It thereby appeared to protect against developing Abs to PF4/heparin (OR 0.29; 95% CI [0.12-0.70], p=0.006). Combined haplotypes cH1/cH8 comprising the short G20 + R13 alleles were less frequent in HIT (OR 0.33; 95% CI [0.11-0.97], p=0.036), and levels of Abs to PF4 in Ab(pos) patients were lower in cH1/cH8 subjects (p=0.019).
CONCLUSION: These results suggest that IL10 promoter microsatellite polymorphisms might influence the immune response against PF4/heparin and the risk of HIT.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22239992     DOI: 10.1016/j.thromres.2011.09.033

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know?

Authors:  Jason H Karnes
Journal:  Pharmacogenomics       Date:  2018-11-06       Impact factor: 2.533

Review 2.  Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT).

Authors:  Junaid Kashir; Ayesha Rahman Ambia; Areez Shafqat; Muhammad Raihan Sajid; Khaled AlKattan; Ahmed Yaqinuddin
Journal:  J Leukoc Biol       Date:  2021-09-01       Impact factor: 6.011

3.  Heparin-induced thrombocytopenia: ELISA optical density value and 4T score in correlation with panel donor platelets activation in functional flow cytometric assay.

Authors:  Klara Železnik; Primož Rožman; Eva Kocjan; Elvira Maličev
Journal:  Blood Transfus       Date:  2020-10-09       Impact factor: 3.443

Review 4.  Diagnosis and management of heparin-induced thrombocytopenia.

Authors:  Grace M Lee; Gowthami M Arepally
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-13       Impact factor: 3.722

5.  Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study.

Authors:  Anika Witten; Juliane Bolbrinker; Andrei Barysenka; Matthias Huber; Frank Rühle; Ulrike Nowak-Göttl; Edeltraut Garbe; Reinhold Kreutz; Monika Stoll
Journal:  J Mol Med (Berl)       Date:  2018-06-22       Impact factor: 4.599

Review 6.  Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.

Authors:  Gowthami M Arepally; Anand Padmanabhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

7.  PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction.

Authors:  Elise Miller; Charles Norwood; Jason B Giles; Rachel Huddart; Jason H Karnes; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2022-04-01       Impact factor: 2.089

Review 8.  Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches.

Authors:  Jason B Giles; Elise C Miller; Heidi E Steiner; Jason H Karnes
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

9.  A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record.

Authors:  Jason H Karnes; Robert M Cronin; Jerome Rollin; Alexander Teumer; Claire Pouplard; Christian M Shaffer; Carmelo Blanquicett; Erica A Bowton; James D Cowan; Jonathan D Mosley; Sara L Van Driest; Peter E Weeke; Quinn S Wells; Tamam Bakchoul; Joshua C Denny; Andreas Greinacher; Yves Gruel; Dan M Roden
Journal:  Thromb Haemost       Date:  2014-12-11       Impact factor: 5.249

Review 10.  Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism.

Authors:  Piotr Rzymski; Bartłomiej Perek; Robert Flisiak
Journal:  Vaccines (Basel)       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.